Literature DB >> 21036386

Human basophils express amphiregulin in response to T cell-derived IL-3.

Yilin Qi1, Darwin J Operario, Christopher M Oberholzer, James J Kobie, R John Looney, Steve N Georas, Tim R Mosmann.   

Abstract

BACKGROUND: Amphiregulin, a member of the epidermal growth factor family, is expressed by activated mouse T(H)2 cells. Amphiregulin produced by mouse hematopoietic cells contributes to the elimination of a nematode infection by a type 2 effector response.
OBJECTIVE: To identify the human peripheral blood cell population expressing amphiregulin.
METHODS: Amphiregulin-expressing cells were identified by flow cytometry of cell surface markers and histologic staining. Histamine and amphiregulin in supernatants were measured by enzyme immunoassay. Quantitative real-time PCR was used to measure mRNA expression.
RESULTS: Stimulation of human PBMCs by anti-CD3 + anti-CD28 antibodies induced expression of amphiregulin mRNA and protein by a non-T-cell population. The amphiregulin-producing cells were basophils, as judged by morphology and expression of CD203c and CD123 (IL-3 receptor α chain). Activated mouse basophils also produced amphiregulin. Amphiregulin expression by basophils in response to anti-TCR stimulation required IL-3 produced by T cells, and IL-3 alone induced high levels of amphiregulin expression by purified basophils. Amphiregulin was expressed at much higher levels when human basophils were stimulated by IL-3 than by IgE cross-linking, whereas the opposite was true for IL-4 expression and histamine release. Heparin-binding epidermal growth factor-like growth factor was also expressed by IL-3-stimulated human basophils. PBMCs from human subjects with asthma contained significantly higher numbers of basophils able to produce amphiregulin compared with controls with or without allergy.
CONCLUSION: IL-3 can induce basophils to express high levels of amphiregulin, which may contribute to tissue remodeling during type 2 immune responses such as asthma.
Copyright © 2010 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21036386      PMCID: PMC2998547          DOI: 10.1016/j.jaci.2010.08.040

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  39 in total

Review 1.  Airway modeling and remodeling in the pathogenesis of asthma.

Authors:  Stephanie M Warner; Darryl A Knight
Journal:  Curr Opin Allergy Clin Immunol       Date:  2008-02

2.  Amphiregulin, a TH2 cytokine enhancing resistance to nematodes.

Authors:  Dietmar M Zaiss; Li Yang; Pranav R Shah; James J Kobie; Joseph F Urban; Tim R Mosmann
Journal:  Science       Date:  2006-12-15       Impact factor: 47.728

Review 3.  Strategies for targeting T-cells in allergic diseases and asthma.

Authors:  I H Heijink; A J M Van Oosterhout
Journal:  Pharmacol Ther       Date:  2006-07-11       Impact factor: 12.310

4.  Amphiregulin production by human eosinophils.

Authors:  Kenji Matsumoto; Shuhei Fukuda; Yuri Nakamura; Hirohisa Saito
Journal:  Int Arch Allergy Immunol       Date:  2009-06-03       Impact factor: 2.749

5.  Human basophils secrete IL-3: evidence of autocrine priming for phenotypic and functional responses in allergic disease.

Authors:  John T Schroeder; Kristin L Chichester; Anja P Bieneman
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

6.  Amphiregulin is an essential mediator of estrogen receptor alpha function in mammary gland development.

Authors:  Laura Ciarloni; Sonia Mallepell; Cathrin Brisken
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-16       Impact factor: 11.205

7.  Interleukin-3 promotes the expression of E-NPP3/CD203C on human blood basophils in healthy subjects and in patients with birch pollen allergy.

Authors:  A W Hauswirth; K Sonneck; S Florian; M T Krauth; A Bohm; W R Sperr; R Valenta; G H Schernthaner; D Printz; G Fritsch; H J Buhring; P Valent
Journal:  Int J Immunopathol Pharmacol       Date:  2007 Apr-Jun       Impact factor: 3.219

8.  Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2).

Authors:  Daniel W Lambert; Mike Yarski; Fiona J Warner; Paul Thornhill; Edward T Parkin; A Ian Smith; Nigel M Hooper; Anthony J Turner
Journal:  J Biol Chem       Date:  2005-06-27       Impact factor: 5.157

9.  MHC class II-dependent basophil-CD4+ T cell interactions promote T(H)2 cytokine-dependent immunity.

Authors:  Jacqueline G Perrigoue; Steven A Saenz; Mark C Siracusa; Eric J Allenspach; Betsy C Taylor; Paul R Giacomin; Meera G Nair; Yurong Du; Colby Zaph; Nico van Rooijen; Michael R Comeau; Edward J Pearce; Terri M Laufer; David Artis
Journal:  Nat Immunol       Date:  2009-05-24       Impact factor: 25.606

10.  Human peripheral blood basophils primed by interleukin 3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation.

Authors:  T Brunner; C H Heusser; C A Dahinden
Journal:  J Exp Med       Date:  1993-03-01       Impact factor: 14.307

View more
  13 in total

1.  Amphiregulin Confers Regulatory T Cell Suppressive Function and Tumor Invasion via the EGFR/GSK-3β/Foxp3 Axis.

Authors:  Sihua Wang; Yuan Zhang; Yan Wang; Ping Ye; Jun Li; Huabin Li; Qingqing Ding; Jiahong Xia
Journal:  J Biol Chem       Date:  2016-07-18       Impact factor: 5.157

2.  Transcriptional Heterogeneity of Mast Cells and Basophils upon Activation.

Authors:  Krishan D Chhiba; Chia-Lin Hsu; Sergejs Berdnikovs; Paul J Bryce
Journal:  J Immunol       Date:  2017-05-05       Impact factor: 5.422

Review 3.  New insights into basophil heterogeneity.

Authors:  Landon K Oetjen; Mario Noti; Brian S Kim
Journal:  Semin Immunopathol       Date:  2016-05-13       Impact factor: 9.623

Review 4.  Basophils and allergic inflammation.

Authors:  Mark C Siracusa; Brian S Kim; Jonathan M Spergel; David Artis
Journal:  J Allergy Clin Immunol       Date:  2013-10       Impact factor: 10.793

Review 5.  Emerging functions of amphiregulin in orchestrating immunity, inflammation, and tissue repair.

Authors:  Dietmar M W Zaiss; William C Gause; Lisa C Osborne; David Artis
Journal:  Immunity       Date:  2015-02-17       Impact factor: 31.745

6.  Amphiregulin enhances regulatory T cell-suppressive function via the epidermal growth factor receptor.

Authors:  Dietmar M W Zaiss; Jorg van Loosdregt; Andrea Gorlani; Cornelis P J Bekker; Andrea Gröne; Maria Sibilia; Paul M P van Bergen en Henegouwen; Rob C Roovers; Paul J Coffer; Alice J A M Sijts
Journal:  Immunity       Date:  2013-01-17       Impact factor: 31.745

Review 7.  Basophils and skin disorders.

Authors:  Francesco Borriello; Francescopaolo Granata; Gianni Marone
Journal:  J Invest Dermatol       Date:  2014-02-06       Impact factor: 8.551

8.  The acute environment, rather than T cell subset pre-commitment, regulates expression of the human T cell cytokine amphiregulin.

Authors:  Yilin Qi; Darwin J Operario; Steve N Georas; Tim R Mosmann
Journal:  PLoS One       Date:  2012-06-14       Impact factor: 3.240

9.  Regulatory T-cell-intrinsic amphiregulin is dispensable for suppressive function.

Authors:  Katharine Carney; Yu-Mei Ruby Chang; Stephen Wilson; Clare Calnan; Pala S Reddy; Win-Yan Chan; Timothy Gilmartin; Gilberto Hernandez; Lana Schaffer; Steven R Head; Joanne Morley; Amanda de Mestre; Karen Affleck; Oliver A Garden
Journal:  J Allergy Clin Immunol       Date:  2016-03-31       Impact factor: 10.793

10.  Amphiregulin activates regulatory T lymphocytes and suppresses CD8+ T cell-mediated anti-tumor response in hepatocellular carcinoma cells.

Authors:  Chun-Hui Yuan; Xiao-Ming Sun; Cheng-Liang Zhu; Shao-Ping Liu; Long Wu; Hao Chen; Mao-Hui Feng; Ke Wu; Fu-Bing Wang
Journal:  Oncotarget       Date:  2015-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.